These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 1650194)

  • 21. Potentiating effect of ribavirin on the in vitro and in vivo antiretrovirus activities of 2',3'-dideoxyinosine and 2',3'-dideoxy-2,6-diaminopurine riboside.
    Balzarini J; Naesens L; Robins MJ; De Clercq E
    J Acquir Immune Defic Syndr (1988); 1990; 3(12):1140-7. PubMed ID: 2123003
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiviral effects if ribavirin and 6-mercapto-9-tetrahydro-2-furylpurine against dengue viruses in vitro.
    Koff WC; Elm JL; Halstead SB
    Antiviral Res; 1982 May; 2(1-2):69-79. PubMed ID: 7201778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro inhibition of subacute sclerosing panencephalitis virus by the antiviral agent ribavirin.
    Murphy MF
    J Infect Dis; 1978 Aug; 138(2):249-51. PubMed ID: 79625
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro combination of amdoxovir and the inosine monophosphate dehydrogenase inhibitors mycophenolic acid and ribavirin demonstrates potent activity against wild-type and drug-resistant variants of human immunodeficiency virus type 1.
    Borroto-Esoda K; Myrick F; Feng J; Jeffrey J; Furman P
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4387-94. PubMed ID: 15504868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Broad-spectrum synergistic antiviral activity of selenazofurin and ribavirin.
    Kirsi JJ; McKernan PA; Burns NJ; North JA; Murray BK; Robins RK
    Antimicrob Agents Chemother; 1984 Oct; 26(4):466-75. PubMed ID: 6517540
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergistic anti-viral effect of oxanosine and ddI against human immunodeficiency virus.
    Nakamura M; Ogawa T; Yokono A; Nakamori S; Ohno T; Umezawa K
    Biomed Pharmacother; 2005; 59(1-2):47-50. PubMed ID: 15740935
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of cotton rats to evaluate the efficacy of antivirals in treatment of measles virus infections.
    Wyde PR; Moore-Poveda DK; De Clercq E; Neyts J; Matsuda A; Minakawa N; Guzman E; Gilbert BE
    Antimicrob Agents Chemother; 2000 May; 44(5):1146-52. PubMed ID: 10770743
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ribavirin inhibits in vitro hepatitis E virus replication through depletion of cellular GTP pools and is moderately synergistic with alpha interferon.
    Debing Y; Emerson SU; Wang Y; Pan Q; Balzarini J; Dallmeier K; Neyts J
    Antimicrob Agents Chemother; 2014; 58(1):267-73. PubMed ID: 24145541
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biochemical differences among four inosinate dehydrogenase inhibitors, mycophenolic acid, ribavirin, tiazofurin, and selenazofurin, studied in mouse lymphoma cell culture.
    Lee HJ; Pawlak K; Nguyen BT; Robins RK; Sadée W
    Cancer Res; 1985 Nov; 45(11 Pt 1):5512-20. PubMed ID: 2865005
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and antiviral acticity of some phosphates of the broad-spectrum antiviral nucleoside, 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (ribavirin).
    Allen LB; Boswell KH; Khwaja TA; Meyer RB; Sidwell RW; Witkowski JT; Christensen LF; Robins RK
    J Med Chem; 1978 Aug; 21(8):742-6. PubMed ID: 211234
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of vaccinia virus growth by the nucleoside analogue 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (virazole, ribavirin).
    Katz E; Margalith E; Winer B
    J Gen Virol; 1976 Aug; 32(2):327-30. PubMed ID: 1018177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced stimulation by ribavirin of the 5'-phosphorylation and anti-human immunodeficiency virus activity of purine 2'-beta-fluoro-2',3'-dideoxynucleosides.
    Johns DG; Ahluwalia GS; Cooney DA; Mitsuya H; Driscoll JS
    Mol Pharmacol; 1993 Sep; 44(3):519-23. PubMed ID: 8371712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Virazole (1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide; a cytostatic agent.
    Müller WE; Maidhof A; Taschner H; Zahn RK
    Biochem Pharmacol; 1977 Jun; 26(11):1071-5. PubMed ID: 880258
    [No Abstract]   [Full Text] [Related]  

  • 34. Photolabeling probes of ribavirin and EICAR.
    Wu Q; Qu F; Wan J; Xia Y; Peng L
    Nucleosides Nucleotides Nucleic Acids; 2005; 24(5-7):999-1008. PubMed ID: 16248080
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ribavirin induced differentiation of murine erythroleukemia cells.
    Kerr SJ
    Mol Cell Biochem; 1987 Oct; 77(2):187-94. PubMed ID: 3481433
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of lymphocyte proliferative responses by ribavirin.
    Peavy DL; Koff WC; Hyman DS; Knight V
    Infect Immun; 1980 Aug; 29(2):583-9. PubMed ID: 7216427
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anomalous accumulation and decay of 2',3'-dideoxyadenosine-5'-triphosphate in human T-cell cultures exposed to the anti-HIV drug 2',3'-dideoxyinosine.
    Ahluwalia G; Cooney DA; Hartman NR; Mitsuya H; Yarchoan R; Fridland A; Broder S; Johns DG
    Drug Metab Dispos; 1993; 21(2):369-76. PubMed ID: 8097711
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synergistic antiviral effects of ribavirin and the C-nucleoside analogs tiazofurin and selenazofurin against togaviruses, bunyaviruses, and arenaviruses.
    Huggins JW; Robins RK; Canonico PG
    Antimicrob Agents Chemother; 1984 Oct; 26(4):476-80. PubMed ID: 6151377
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and biological evaluation of novel imidazole nucleosides as potential anti-dengue virus agents.
    Okano Y; Saito-Tarashima N; Kurosawa M; Iwabu A; Ota M; Watanabe T; Kato F; Hishiki T; Fujimuro M; Minakawa N
    Bioorg Med Chem; 2019 Jun; 27(11):2181-2186. PubMed ID: 31003866
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inactivation of inosine 5'-monophosphate dehydrogenase by the antiviral agent 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide 5'-monophosphate.
    Wang W; Papov VV; Minakawa N; Matsuda A; Biemann K; Hedstrom L
    Biochemistry; 1996 Jan; 35(1):95-101. PubMed ID: 8555204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.